ExploreWatchlistsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Net income margin (%)

ROHTO PHARMACEUTICAL CO.,LTD. (4527)

Market cap
¥565.1B
P/E ratio
16.4x
Rohto Pharmaceutical manufactures and sells eye care, skin care, and oral medications globally through its subsidiaries including Mentholatum brands.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 202510-13.33%
Mar 31, 202411.6+4.67%
Mar 31, 202311.1+4.53%
Mar 31, 202210.6+14.52%
Mar 31, 20219.3+13.05%
Mar 31, 20208.2+53.00%
Mar 31, 20195.3-1.62%
Mar 31, 20185.4-16.07%
Mar 31, 20176.5+18.90%
Mar 31, 20165.4-4.21%
Mar 31, 20155.7+93.26%
Mar 31, 20142.9-36.48%
Mar 31, 20134.6-0.33%
Mar 31, 20124.6

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat